These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9184730)

  • 41. Switching statins: can we do harm?
    Thomas U
    N Z Med J; 1998 Jan; 111(1058):18. PubMed ID: 9490420
    [No Abstract]   [Full Text] [Related]  

  • 42. Development and pharmacology of fluvastatin.
    Jokubaitis LA
    Br J Clin Pract Suppl; 1994 Dec; (77):11-5. PubMed ID: 19489169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo inhibition profile of cytochrome P450TB (CYP2C9) by (+/-)-fluvastatin.
    Transon C; Leemann T; Vogt N; Dayer P
    Clin Pharmacol Ther; 1995 Oct; 58(4):412-7. PubMed ID: 7586933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuromuscular toxicity in nephrotic patients treated with fluvastatin.
    Gazarin S; Abd-El-Hady H; Gheith O; Rasem M; Saad M; El-Sayed K; Sobh M; Amer G
    J Nephrol; 2002; 15(6):690-5. PubMed ID: 12495286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluvastatin decreases soluble thrombomodulin in cardiac transplant recipients.
    Ambrosi P; Aillaud MF; Habib G; Kreitmann B; Métras D; Luccioni R; Bouvenot G; Juhan-Vague I
    Thromb Haemost; 2000 Jan; 83(1):46-8. PubMed ID: 10669153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Severe rhabdomyolysis after laparoscopic surgery for adenocarcinoma of the rectum in two patients treated with statins.
    Forestier F; Breton Y; Bonnet E; Janvier G
    Anesthesiology; 2002 Oct; 97(4):1019-21. PubMed ID: 12357176
    [No Abstract]   [Full Text] [Related]  

  • 47. Fluvastatin plus fish oil are more effective on cardiovascular risk factors than fluvastatin alone.
    Singer P
    Prostaglandins Leukot Essent Fatty Acids; 2005 May; 72(5):379-80. PubMed ID: 15850720
    [No Abstract]   [Full Text] [Related]  

  • 48. Seven cases of interaction between warfarin and cyclooxygenase-2 inhibitors.
    Stading JA; Skrabal MZ; Faulkner MA
    Am J Health Syst Pharm; 2001 Nov; 58(21):2076-80. PubMed ID: 11715832
    [No Abstract]   [Full Text] [Related]  

  • 49. Diminished anticoagulant effects of warfarin with concomitant mercaptopurine therapy.
    Martin LA; Mehta SD
    Pharmacotherapy; 2003 Feb; 23(2):260-4. PubMed ID: 12587816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fatal lupus-like syndrome and ARDS induced by fluvastatin.
    Sridhar MK; Abdulla A
    Lancet; 1998 Jul; 352(9122):114. PubMed ID: 9672281
    [No Abstract]   [Full Text] [Related]  

  • 51. Spinal epidural haematoma as a result of warfarin/fluconazole drug interaction.
    Allison EJ; McKinney TJ; Langenberg JN
    Eur J Emerg Med; 2002 Jun; 9(2):175-7. PubMed ID: 12131644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Warfarin and nonsteroidal antiinflammatory drugs: why not?
    Frazee LA; Reed MD
    Ann Pharmacother; 1995 Dec; 29(12):1289-91. PubMed ID: 8672837
    [No Abstract]   [Full Text] [Related]  

  • 53. Analysis of purported erythromycin-warfarin interaction.
    Horn JR
    Am J Health Syst Pharm; 2010 Jun; 67(12):966; author reply 966, 968. PubMed ID: 20516463
    [No Abstract]   [Full Text] [Related]  

  • 54. Does fluvastatin really have an antioxidant effect in humans?
    Nagase S; Hirayama A; Ueda A; Hirayama K; Terao J; Koyama A
    Kidney Int; 2005 Sep; 68(3):1373-4. PubMed ID: 16105083
    [No Abstract]   [Full Text] [Related]  

  • 55. Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease.
    Golomb BA; Evans MA
    Med J Aust; 2007 Aug; 187(4):253. PubMed ID: 17708735
    [No Abstract]   [Full Text] [Related]  

  • 56. In Reply to Keskin and Orhan.
    Kılıç S; Çelik A; Zoghi M
    Balkan Med J; 2019 Jul; 36(4):256-256. PubMed ID: 31291706
    [No Abstract]   [Full Text] [Related]  

  • 57. Probable interaction of warfarin and acarbose.
    Morreale AP; Janetzky K
    Am J Health Syst Pharm; 1997 Jul; 54(13):1551-2. PubMed ID: 9217947
    [No Abstract]   [Full Text] [Related]  

  • 58. Interaction of warfarin with glucosamine--chondroitin.
    Scott GN
    Am J Health Syst Pharm; 2004 Jun; 61(11):1186; author reply 1186. PubMed ID: 15237575
    [No Abstract]   [Full Text] [Related]  

  • 59. Comment: HMG-CoA reductase inhibitor-induced impotence.
    Boyd IW
    Ann Pharmacother; 1996 Oct; 30(10):1199. PubMed ID: 8893134
    [No Abstract]   [Full Text] [Related]  

  • 60. The authors reply.
    Procino G; Milano S; Nicoletti MC; Carmosino M; Svelto M
    Kidney Int; 2015 Apr; 87(4):862-3. PubMed ID: 25826553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.